-
1.发明申请公开(公告)号：US20190284281A1
公开(公告)日：2019-09-19
申请号：US16095475
申请日：2017-04-27
Applicant: Biogen MA Inc.
Inventor： Mark R.H. Krebs , David Dai , Shantanu Sule , Dania Rabah , David Martin
Abstract: Formulations and dosage regimens of anti-Blood Dendritic Cell Antigen 2 (BDCA2) antibodies are provided. These formulations and dosage regimens find use in the treatment of BDCA2-associated disorders such as systematic lupus erythematosus, cutaneous lupus eiythernatosus, and discoid lupus erythematosus, and cytokine release syndrome.
Search Results
1
records
(took 0.012 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
